
Odaberite svoju etiketu
prikazano izravno na bočiciBPC + TB + KPV Blend
Healing
- Šalje se iz Njemačke
Narudžba
- DHL s praćenjem
- Diskretno pakiranje
Na prvi pogled
BPC + TB + KPV Blend u brojkama
Ključni podaci iz našeg leksikona.
Cijeli članak u leksikonu- Class
- Healing blendBPC + TB + KPV
- Use
- Subcutaneousin mg, a third each
- Sizes
- 30 mg1 size in the shop
What studies show
The source in the lexicon- Dalmasso et al., Gastroenterology, 2008
Recenzije
Što kažu kupci
Samo stvarne narudžbe koje su uključivale BPC + TB + KPV Blend.
Sve recenzijeZa BPC + TB + KPV Blend još nema laboratorijske analize. Glasaj za toDajte sami na testiranje, mi plaćamo polaSve laboratorijske analize
Znanje
Sve o BPC + TB + KPV Blend
Detaljne informacije uskoro.
Doziranje
Učitavanje podataka o doziranju …
Dobro je imati
Što vam uz to treba
Bakteriostatska voda automatski se dodaje u košaricu. Štrcaljke i maramice jednim klikom.
Inzulinske štrcaljke
10 kom. · 5.50 €
Alkoholne maramice
50 kom. · 10 €
Koliko vode?
Jedinice na štrcaljki za veličinu vaše bočice.
Otvori kalkulator →Are there studies on this blend?
No. As of 26 October 2026 ClinicalTrials.gov lists no trial with KPV and none with two of the three components together. Everything here comes from studies on the single compounds.
What is KPV supposed to add to the blend?
KPV is the last three building blocks of alpha-MSH. The transporter PepT1 carries it into gut and immune cells, where it inhibits the NF-κB and MAP kinase pathways even at nanomolar amounts. In colitis models in mice KPV in the drinking water reduced inflammation, also in animals without a functional MC1R. Whether it adds anything when injected together with BPC-157 and TB-500 has not been tested.
Do BPC-157 and TB-500 work better together?
That is not established. In 32 rats with a repaired Achilles tendon each on its own was linked to better tendon tissue, above all TB-500. The combination gave no advantage over either alone. KPV was not part of this study.
What do the studies on the single components show?
With KPV drops all 8 corneal wounds closed in rabbits within 60 hours, none with placebo. Thymosin beta-4 sped up wound closure in rats by up to 61 percent. BPC-157 promoted new blood vessels via the receptor VEGFR2. All animal and cell studies.
Which human studies exist?
None on KPV. For BPC-157 three small studies with 30 people in total, all without a control group, plus a planned phase 1 trial. Thymosin beta-4 was tested into a vein in healthy adults and in phase 2 after heart attack.
Which side effects are known?
None for the blend. The three human studies on BPC-157 saw no treatment-related side effects, with very low certainty. 40 healthy people tolerated thymosin beta-4 into a vein without serious side effects. For KPV human data are missing entirely.
Povezano
Srodni proizvodi
BPC-157
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
4 veličine
Laboratorijski testirano
= od 5.2 €/bočica
TB-500 (Thymosin B4)
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
3 veličine
Laboratorijski testirano
= od 18.8 €/bočica
TB-500 FRAG
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
1 veličina
= 24.8 €/bočica
BPC + TB Blend
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
3 veličine
Laboratorijski testirano
= od 24.8 €/bočica
BPC + TB + KPV Blend